-
Posted by
Two Blokes Jun 12 -
Filed in
Stock
-
5 views
MEXICO CITY , June 12, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of Mexico's leading pharmaceutical and personal care companies with a growing international footprint, announced that on June 11, 2025, it completed the full early amortization of its debt certificates listed under the ticker symbol "LAB 23.
